Eagle Claw Capital Managment, LLC Vertex Pharmaceuticals Inc Transaction History
Eagle Claw Capital Managment, LLC
- $542 Million
- Q2 2024
A detailed history of Eagle Claw Capital Managment, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 7,425 shares of VRTX stock, worth $3.73 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
7,425
Previous 7,525
1.33%
Holding current value
$3.73 Million
Previous $3.15 Million
10.65%
% of portfolio
0.64%
Previous 0.58%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,716Shares Held
225MCall Options Held
1.19MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA26.7MShares$13.4 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$11.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.89 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.29 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $129B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...